Skip to main content

Articles

Page 4 of 38

  1. Metabolic syndrome (MS) represents a cluster of metabolic abnormalities. Insulin resistance is a major component of the syndrome. We analyze in this study the relationship between body fat composition and MS i...

    Authors: Hourfil-Gabin Ntougou Assoumou, Vincent Pichot, Jean-Claude Barthelemy, Sébastien Celle, Arnauld Garcin, Thierry Thomas and Frédéric Roche
    Citation: Diabetology & Metabolic Syndrome 2023 15:98
  2. Arteriosclerosis and non-alcoholic fatty liver disease are major complications of diabetes mellitus. Hyperglycemia, insulin resistance, obesity, and metabolic syndrome are associated with the progression of th...

    Authors: Yuriko Hajika, Yuji Kawaguchi, Kenji Hamazaki and Yasuro Kumeda
    Citation: Diabetology & Metabolic Syndrome 2023 15:97
  3. Proton pump inhibitors (PPIs) are common and widely used for gastrointestinal-related disorders. Lansoprazole is one of PPIs with potential benefits of anti-inflammation, reduced oxidative stress, and anti-dia...

    Authors: Ming-Hsun Lin, Wen‐Tung Wu, Yong-Chen Chen, Tsung-Kun Lin, Yu‐Ching Chou and Chien‐An Sun
    Citation: Diabetology & Metabolic Syndrome 2023 15:96
  4. For patients with diabetes, high-frequency and -amplitude glycemic variability may be more harmful than continuous hyperglycemia; however, there is still a lack of screening indicators that can quickly and eas...

    Authors: Rui Shi, Lei Feng, Yan-Mei Liu, Wen-Bo Xu, Bei-Bei Luo, Ling-Tong Tang, Qian-Ye Bi and Hui-Ying Cao
    Citation: Diabetology & Metabolic Syndrome 2023 15:95
  5. Non-alcoholic fatty liver disease (NAFLD) is associated with atrial fibrillation (AF). Insulin resistance (IR) is the main cause of the high prevalence of AF in NAFLD patients. The triglyceride-glucose index (...

    Authors: Yao Zhang, Leigang Wang, Jiaxin Qi, Bing Yu, Jianqi Zhao, Lin Pang, Wenjing Zhang and Liang Bin
    Citation: Diabetology & Metabolic Syndrome 2023 15:94
  6. Empagliflozin, a sodium–glucose co-transporter 2 inhibitor (SGLT2i), has been reported to significantly reduce the risk of heart failure in multiple clinical studies. However, the underlying mechanisms remain ...

    Authors: Lin Zhang, Heming Zhang, Xiuzhu Xie, Ruping Tie, Xiaolin Shang, Qianqian Zhao, Junjie Xu, Liyuan Jin, Jinying Zhang and Ping Ye
    Citation: Diabetology & Metabolic Syndrome 2023 15:93
  7. As a CGM-derived indicator, ‘time in range’ (TIR) is emerging as a key indicator for accurate assessment of glycaemic control. However, there is few report focusing on the correlation of TIR with albumuria and...

    Authors: Xuguang Jin, Xinyi Yang, Yixin Xu, Jingjing Liang, Chunyan Liu, Qingyu Guo, Wei Wang, Zhouqin Feng, Yanyu Yuan, Hui Zhou, Zhen Zhang, Wenwen Jiang, Yue Liang, Bin Lu, Jiaqing Shao, Yong Zhong…
    Citation: Diabetology & Metabolic Syndrome 2023 15:92
  8. There are few studies and inconsistent findings on the role of sleep-related parameters in the development of metabolic syndrome (MetS) among youths. In this study, we aim to investigate the relationship betwe...

    Authors: Majid Kazemi, Parvin Khalili, Mahsa Kazemi, Hadi Hasani, Marjan Sadeghi and Zahra Jamali
    Citation: Diabetology & Metabolic Syndrome 2023 15:91
  9. Differentiating between type 1 diabetes (T1D) and type 2 diabetes (T2D) can be difficult in adults. The aim of this study was to determine the frequency of diagnostic reclassification from T2D to T1D, the char...

    Authors: Raúl Rodríguez Escobedo, Carmen Lambert, Paula Morales Sánchez, Elías Delgado Álvarez and Edelmiro Menéndez Torre
    Citation: Diabetology & Metabolic Syndrome 2023 15:90
  10. Few studies have examined the relationship between malnutrition, as defined by the Geriatric Nutrition Risk Index (GNRI), and all-cause mortality and cardiovascular mortality events, particularly in persons wi...

    Authors: Xia Shen, Long Yang, Xue Gu, Yuan-Yuan Liu and Lei Jiang
    Citation: Diabetology & Metabolic Syndrome 2023 15:89
  11. Authors: Fei Chen, Jinping Wang, Xiaoping Chen, Liping Yu, Yali An, Qiuhong Gong, Bo Chen, Shuo Xie, Lihong Zhang, Ying Shuai, Fang Zhao, Yanyan Chen, Guangwei Li and Bo Zhang
    Citation: Diabetology & Metabolic Syndrome 2023 15:88

    The original article was published in Diabetology & Metabolic Syndrome 2023 15:62

  12. Finerenone is a third-generation mineralocorticoid receptor antagonists, which has shown good cardiac function improvement in patients with type 2 diabetes in large-scale clinical trials. However, its specific...

    Authors: Tao Jin, Xiangrui Fu, Ming Liu and Fengshuang An
    Citation: Diabetology & Metabolic Syndrome 2023 15:87
  13. Glycogen storage disease type 1b (GSD1b) is an autosomal recessive lysosomal storage disease caused by defective glucose-6-phosphate transporter encoded by SLC37A4 leading to the accumulation of glycogen in va...

    Authors: Latifa Chkioua, Yessine Amri, Chayma Sahli, Ferdawes Ben Rhouma, Amel Ben Chehida, Neji Tebib, Taieb Messaoud, Hassen Ben Abdennebi and Sandrine Laradi
    Citation: Diabetology & Metabolic Syndrome 2023 15:86
  14. Recurrent DKA (rDKA) remains an acute type 1 diabetes complication even in post-insulin era. This study aimed to analyze the predictors and effects of rDKA on the mortality of patients with type 1 diabetes.

    Authors: Sarah S. Santos, Luana A. L. Ramaldes, Patricia M. Dualib, Monica A. L. Gabbay, João R. Sá and Sergio A. Dib
    Citation: Diabetology & Metabolic Syndrome 2023 15:85
  15. Osteoporosis, a chronic complication of diabetes mellitus, is characterized by a reduction in bone mass, destruction of bone microarchitecture, decreased bone strength, and increased bone fragility. Because of...

    Authors: Kairan Bao, Yinghua Jiao, Lei Xing, Fang Zhang and Faming Tian
    Citation: Diabetology & Metabolic Syndrome 2023 15:84
  16. Diabetic autonomic neuropathy (DAN) is a frequent complication in people with diabetes whose screening is often neglected. This study aimed to evaluate DAN through practical tools in people with diabetes in a ...

    Authors: Ana Raquel Souza de Azevedo Vieira, Lara Benigno Porto-Dantas, Flaviene Alves do Prado Romani, Patrícia Souza Carvalho, Rodica Pop-Busui and Hermelinda Cordeiro Pedrosa
    Citation: Diabetology & Metabolic Syndrome 2023 15:83
  17. We examined the longitudinal association between (change in) physical activity (PA) with new onset of five risk factors of metabolic syndrome among 657 middle-aged adults (mean age 44.1 (standard deviation (SD...

    Authors: Laura Cleven, Anna Dziuba, Janina Krell-Roesch, Steffen C. E. Schmidt, Klaus Bös, Darko Jekauc and Alexander Woll
    Citation: Diabetology & Metabolic Syndrome 2023 15:82
  18. Glycemic monitoring has become critical during the COVID-19 pandemic because of poor prognosis in diabetes. Vaccines were key in reducing the spread of infection and disease severity but data were lacking on e...

    Authors: Cheng-Wei Lin, Shih-Yuan Hung and I-Wen Chen
    Citation: Diabetology & Metabolic Syndrome 2023 15:81
  19. Observational studies demonstrated a bidirectional association between type 2 diabetes (T2D) and hypertension, whereas Mendelian randomization (MR) analyses supported the causality from T2D to hypertension but...

    Authors: Haotian Wang, Yuan Li, Weijie Cao, Jie Zhang, Mingyang Cao, Xiaoni Meng, Di Liu and Youxin Wang
    Citation: Diabetology & Metabolic Syndrome 2023 15:80
  20. Hypoglycemia in type 1 diabetes (T1D) is associated with mortality and morbidity, especially when awareness of hypoglycemia is impaired. This study aimed to investigate the protective and risk factors for impa...

    Authors: Naoki Sakane, Ken Kato, Sonyun Hata, Erika Nishimura, Rika Araki, Kunichi kouyama, Masako Hatao, Yuka Matoba, Yuichi Matsushita, Masayuki Domichi, Akiko Suganuma, Seiko Sakane, Takashi Murata and Fei Ling Wu
    Citation: Diabetology & Metabolic Syndrome 2023 15:79
  21. Metabolic syndrome is associated with type 2 diabetes and its prevalence is increasing worldwide in young adults. We aimed to determine whether cumulative exposure to metabolic syndrome is associated with type...

    Authors: Min-Kyung Lee, Jae-Hyuk Lee, Seo Young Sohn, Jiyeon Ahn, Oak-Kee Hong, Mee-Kyoung Kim, Ki-Hyun Baek, Ki-Ho Song, Kyungdo Han and Hyuk-Sang Kwon
    Citation: Diabetology & Metabolic Syndrome 2023 15:78
  22. The transition to metabolically unhealthy obesity (MUO) is driven by the limited expandability of adipose tissue (AT). Familial Partial Lipodystrophy type 2 (FPLD2) is an alternative model for AT dysfunction t...

    Authors: Guillaume Treiber, Marie-Paule Gonthier, Alice Guilleux, Samir Medjane, Oriane Bonfanti, Muriel Cogne, Olivier Meilhac and Estelle Nobecourt
    Citation: Diabetology & Metabolic Syndrome 2023 15:77
  23. Vitamin D supplementation exerts several supporting effects on improving glycemic status, however, results are inconclusive. Thus, in the present study, we aimed to conduct an umbrella of meta-analysis regardi...

    Authors: Vali Musazadeh, Zeynab Kavyani, Naghmeh Mirhosseini, Parvin Dehghan and Mahdi Vajdi
    Citation: Diabetology & Metabolic Syndrome 2023 15:76
  24. To understand the prevalence of hypertension and hyperlipidaemia as well as the current status of glycaemic control and its influencing factors among type 2 diabetes mellitus patients in the community in South...

    Authors: Zhiyu Zhai, Yunou Yang, Guozhen Lin, Weiquan Lin, Jiagang Wu, Xiangyi Liu, Shijia Zhang, Qin Zhou, Hui Liu and Guang Hao
    Citation: Diabetology & Metabolic Syndrome 2023 15:73
  25. N-terminal B-type natriuretic peptide (NT-proBNP) discriminates mortality risk in diabetes mellitus (DM) and in heart failure (HF) populations. Whether DM status modifies the association between NT-proBNP and ...

    Authors: Weida Qiu, Anping Cai, Xiaoju Xiao, Zhiping Gao, Yingqing Feng and Liwen Li
    Citation: Diabetology & Metabolic Syndrome 2023 15:72
  26. Pre-diabetes is a condition in which blood glucose levels are high but not as high as in diabetic patients. However, it can lead to diabetes, making it a serious global health issue. Previous studies have show...

    Authors: Mina AkbariRad, Somayeh Sadat Shariatmaghani, Bibi Marjan Razavi, Hassan Mehrad Majd, Zeinab Shakhsemampour, Mehrdad Sarabi, Maryam Jafari, Setareh Azarkar, AmirAli Moodi Ghalibaf and Zahra Mazloum Khorasani
    Citation: Diabetology & Metabolic Syndrome 2023 15:71
  27. There is a considerable burden of sedentary time in European adults. We aimed to quantify the differences in adiposity and cardiometabolic health associated with theoretically exchanging sedentary time for alt...

    Authors: Paul J. Collings, Anne Backes, Gloria A. Aguayo, Guy Fagherazzi and Laurent Malisoux
    Citation: Diabetology & Metabolic Syndrome 2023 15:70
  28. We recently conducted the first longitudinal study comparing cardiometabolic risk indicators (CMRIs) between a cohort of individuals with bipolar disorders (BDs) and controls from the general population. Here,...

    Authors: Hemen Najar, Alina Karanti, Erik Pålsson and Mikael Landén
    Citation: Diabetology & Metabolic Syndrome 2023 15:69
  29. Changes in the arginine metabolites asymmetric dimethyl-L-arginine (ADMA) and L-homoarginine and acute blood glucose concentrations have been shown to cause endothelial dysfunction and be independently associa...

    Authors: Tien F. Lee, Sara Tommasi, Andrew Bersten, Leonie K. Heilbronn, Salvatore Sotgia, Angelo Zinellu, Ciriaco Carru, Arduino A. Mangoni and Morton G. Burt
    Citation: Diabetology & Metabolic Syndrome 2023 15:68
  30. Diabetes mellitus (DM), a hyperglycemic condition, occurs due to the failure of insulin secretion and resistance. This study investigated the combined effects of exercise training and melatonin (Mel) on the fu...

    Authors: Afshin Rahbarghazi, Karim Azali Alamdari, Reza Rahbarghazi and Hanieh Salehi-Pourmehr
    Citation: Diabetology & Metabolic Syndrome 2023 15:67
  31. Cardiometabolic disease is a clinical syndrome characterized by multiple metabolic disorders, with atherosclerosis as the core and cardiovascular and cerebrovascular events as the outcome. Drug research and de...

    Authors: Chen Li, Jun Hao, Yitian Zheng, Chuangshi Wang, Jie Yang, Wenyao Wang, Kuo Zhang, Chunli Shao, Wen Hui, Jiancheng Wang, Wei Li and Yi-Da Tang
    Citation: Diabetology & Metabolic Syndrome 2023 15:66
  32. Metabolic syndrome (MS) is related to lung dysfunction. However, its impact according to insulin resistance (IR) remains unknown. Therefore, we evaluated whether the relation of MS with lung dysfunction differ...

    Authors: Jonghoo Lee, Hye Kyeong Park, Min-Jung Kwon, Soo-Youn Ham, Hyun-Il Gil, Si-Young Lim and Jae-Uk Song
    Citation: Diabetology & Metabolic Syndrome 2023 15:65
  33. To use 18 F-FDG microPET dynamic imaging to preliminarily identify the changes of myocardial glucose metabolism corresponding to different functional phenotypes of diabetic cardiomyopathy (DCM) in mice and elucid...

    Authors: Xiaoliang Shao, Yaqi Liu, Mingge Zhou, Min Xu, Yuqi Chen, Hongbo Huang, Jianguo Lin and Yuetao Wang
    Citation: Diabetology & Metabolic Syndrome 2023 15:64
  34. The aim of this paper was to investigate the effects of semaglutide on phosphorylated protein expression, and its neuroprotective mechanism in hippocampi of high-fat-diet-induced obese mice. In total, 16 obese...

    Authors: Xiaoyi Chen, Liang Ma, Kexin Gan, Xiaoyu Pan and Shuchun Chen
    Citation: Diabetology & Metabolic Syndrome 2023 15:63
  35. This study aimed to develop cardiovascular disease (CVD) risk equations for Chinese patients with newly diagnosed type 2 diabetes (T2D) to predict 10-, 20-, and 30-year of risk.

    Authors: Fei Chen, Jinping Wang, Xiaoping Chen, Liping Yu, Yali An, Qiuhong Gong, Bo Chen, Shuo Xie, Lihong Zhang, Ying Shuai, Fang Zhao, Yanyan Chen, Guangwei Li and Bo Zhang
    Citation: Diabetology & Metabolic Syndrome 2023 15:62

    The Correction to this article has been published in Diabetology & Metabolic Syndrome 2023 15:88

  36. Human Immuno-deficiency Virus (HIV) infection and antiretroviral therapy (ART) can cause metabolic disorders such as lipodystrophy, dyslipidemia, and insulin resistance, all of which are symptoms of metabolic ...

    Authors: Derara Girma, Hiwot Dejene, Leta Adugna Geleta, Erean Shigign Malka, Mengistu Tesema, Mukemil Awol and Befekadu Tesfaye Oyato
    Citation: Diabetology & Metabolic Syndrome 2023 15:61
  37. Metabolic health status and levels of adiposity are prone to change over time. Mixed results have been reported regarding the extent by which changes in metabolic health and weight affect cardiometabolic risks...

    Authors: Xuhui Zhang, Jinghan Zhu, Jean H. Kim, Timothy S. Sumerlin, Qi Feng and Jiazhou Yu
    Citation: Diabetology & Metabolic Syndrome 2023 15:60
  38. Luteolin, a common flavonoid in our daily diet, has potent anti-diabetic effects. However, its prognostic impact on type 2 diabetes mellitus (T2DM) is still uncertain. This study aimed to clarify this associat...

    Authors: Wenbin Zhang, Duanbin Li, Yu Shan, Yecheng Tao, Qingqing Chen, Tianli Hu, Menghan Gao, Zhezhe Chen, Hangpan Jiang, Changqin Du, Min Wang and Kai Guo
    Citation: Diabetology & Metabolic Syndrome 2023 15:59
  39. Malnutrition and inflammation are associated with adverse clinical outcomes in patients with diabetes or coronary artery disease (CAD). Prognostic nutritional index (PNI) is a comprehensive and simple indicato...

    Authors: Tianyu Li, Deshan Yuan, Peizhi Wang, Guyu Zeng, Sida Jia, Ce Zhang, Pei Zhu, Ying Song, Xiaofang Tang, Runlin Gao, Bo Xu and Jinqing Yuan
    Citation: Diabetology & Metabolic Syndrome 2023 15:58
  40. Metabolic-associated fatty liver disease (MAFLD), one of the most common liver diseases, is detected in patients with concomitant hepatic steatosis and Type 2 Diabetes (T2D). We looked into the relationship be...

    Authors: Maryam Namakchian, Soghra Rabizadeh, Sara Seifouri, Hassan Asadigandomani, Melika Arab Bafrani, Kiana Seifouri, Foroogh Alborzi Avanaki, Armin Rajab, Manouchehr Nakhjavani and Alireza Esteghamati
    Citation: Diabetology & Metabolic Syndrome 2023 15:57
  41. Nonalcoholic fatty liver disease (NAFLD) has a multidirectional relationship with metabolic syndrome (MetS) and used to be considered a hepatic manifestation of MetS. Perirenal fat, as a part of visceral adipo...

    Authors: Li Wang, Yuning Pan, Xianwang Ye, Yongmeng Zhu, Yandong Lian, Hui Zhang, Miao Xu, Mengxiao Liu and Xinzhong Ruan
    Citation: Diabetology & Metabolic Syndrome 2023 15:56
  42. Several instruments are used to identify depression among patients with diabetes and have been compared for their test criteria, but, not for the overlaps and differences, for example, in the sociodemographic ...

    Authors: Ute Linnenkamp, Veronika Gontscharuk, Katherine Ogurtsova, Manuela Brüne, Nadezda Chernyak, Tatjana Kvitkina, Werner Arend, Imke Schmitz-Losem, Johannes Kruse, Norbert Hermanns, Bernd Kulzer, Silvia M. A. A. Evers, Mickaël Hiligsmann, Barbara Hoffmann, Andrea Icks and Silke Andrich
    Citation: Diabetology & Metabolic Syndrome 2023 15:54
  43. Low muscle mass likely results in reduced capacity for glucose disposal, leading to a significant but under-appreciated contribution to increasing the risk of diabetes. But few prospective studies have investi...

    Authors: Yiting Xu, Tingting Hu, Yun Shen, Yufei Wang, Yuqian Bao and Xiaojing Ma
    Citation: Diabetology & Metabolic Syndrome 2023 15:53
  44. Type 1 diabetes mellitus (T1DM) patients are at an increased risk for non-alcoholic fatty liver disease (NAFLD). This study aimed to evaluate the clinical criteria associated with the diagnosis of Non-Alcoholi...

    Authors: Hanaa Reyad Abdallah, Eman Refaat Youness, Manar Maher Bedeir, Marwa W. Abouelnaga, Wafaa M. Ezzat, Yasser Elhosary, Hazem Mohamed El-Hariri, Mona Abd Elmotaleb A. Hussein, Heba R. Ahmed and Rasha Eladawy
    Citation: Diabetology & Metabolic Syndrome 2023 15:52
  45. Persistence of β cell-function in Type 1 diabetes (T1D) is associated with glycaemia stability and lower prevalence of microvascular complications. We aimed to assess the prevalence of residual C- peptide secr...

    Authors: Monica A. L. Gabbay, Felipe Crispim and Sergio A. Dib
    Citation: Diabetology & Metabolic Syndrome 2023 15:51
  46. Coronary heart disease (CHD) is not only a macrovascular complication of type 2 diabetes mellitus (T2DM). Cardiovascular disease (CVD) is one of the leading causes of mortality among individuals with T2DM. Red...

    Authors: Xiaojuan Jiao, Qin Zhang, Ping Peng and Yunfeng Shen
    Citation: Diabetology & Metabolic Syndrome 2023 15:50
  47. Gestational diabetes mellitus (GDM) is associated with retarded lung development and poor lung health in offspring. Mammalian target of rapamycin (mTOR) is a key regulator of vasculogenesis and angiogenesis. T...

    Authors: Qingqing Luo, Xinqun Chai, Xiaoyan Xin, Weixiang Ouyang and Feitao Deng
    Citation: Diabetology & Metabolic Syndrome 2023 15:49

New Content Item

The official journal of the Brazilian Diabetes Society.

Annual Journal Metrics

  • 2022 Citation Impact
    4.8 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.476 - SNIP (Source Normalized Impact per Paper)
    1.195 - SJR (SCImago Journal Rank)

    2022 Speed
    3 days submission to first editorial decision for all manuscripts (Median)
    84 days submission to accept (Median)

    2022 Usage 
    1,137,953 downloads
    3,375 Altmetric mentions